share_log

中国生物制药(01177.HK)ESG表现获得标普全球、富时罗素认可

Finet News ·  Jul 19 04:42

【财华社讯】中国生物制药(01177.HK)公布,集团凭借持续且稳定的环境、社会及企业管治(ESG)实践表现,已获得标普全球(S&P Global)、富时罗素(FTSE Russell)等多家全球可持续发展权威机构的认可。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment